China has developed the capacity to produce enough Covid-19 test kits to screen 51 million people daily, providing “strong” logistical support to pandemic control measures, according to the country’s drugs and medical devices regulatory body.
The National Medical Products Administration (NMPA) said it had approved 68 Covid-19 test products by the end of last year – including reagents for 34 PCR (polymerase chain reaction) tests, 31 antibody tests and three antigen tests.
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
